HealthTronics Plans 300-Patient Postmarket Study Of OssaTron For Heel Pain
This article was originally published in The Gray Sheet
Executive Summary
HealthTronics is planning a 300-patient, 12-week post-market study of the OssaTron orthopedic lithotriptor for treatment of plantar fasciitis (heel spurs), following FDA approval of the device Oct. 12.